Suppr超能文献

子宫内间充质干细胞移植后的胎盘转运。

Transplacental traffic after in utero mesenchymal stem cell transplantation.

机构信息

Laboratory for Prenatal Medicine, Department of Obstetrics and Gynecology, University Hospital, Basel, Switzerland.

出版信息

Stem Cells Dev. 2010 Sep;19(9):1385-92. doi: 10.1089/scd.2009.0434.

Abstract

Transplacental traffic of fetal progenitor and differentiated cells is a well-known phenomenon in pregnancies. We hypothesize that intrauterine stem cell transplantation leads to microchimerism in the dams and that this is gestational age-dependent. EGFP+ fetal liver-derived mesenchymal stem cell (MSC) (10(5) per fetus) were injected intraperitoneally into congeneic and allogeneic recipient fetuses at E12 versus E13.5 of murine pregnancy (56 dams). Engraftment in maternal organs was evaluated using TaqMan quantitative polymerase chain reaction (PCR) and fluorescence microscopy during pregnancy (1, 3, and 7 days after in utero transplantation [IUT]) and after delivery (1 and 4 weeks after delivery). One day after IUT donor cells were mainly found in the placenta (E12: 9/10 dams vs. E13.5: 4/8 dams) and laparotomy site (E12: 5/10 dams vs. E13.5: 4/8 dams). Three days after IUT these probabilities decreased significantly in the placenta to 3/8 and 1/3, respectively, whereas it was increased within the surgical wound to 8/8 and 2/4. One week after IUT donor cells could be detected in other single maternal organs, such as bone marrow or spleen. The surgical wound was chimeric in all dams. One week after delivery the surgical wound was still a major site of engraftment in both groups. E12 IUT resulted in detectable donor cell microchimerism in the maternal bone marrow (3/4), liver (2/4), lungs (1/4), spleen (1/4), and thymus (1/4), whereas engraftment probabilities were lower following E13.5 IUT (BM: 1/4, liver: 2/4, lungs: 1/4, spleen: 1/4, thymus: 0/4). At 4 weeks after delivery persistent microchimerism was found only after E12 IUT in various maternal organs (BM: 1/4, spleen: 1/4, lungs: 1/4) and within newly created surgical wounds (3/4), but completely not in the E13.5 group. Allogeneic IUT did also not result in any detectable long-term fetal microchimerism. An earlier IUT might lead to a higher transplacental traffic of donor MSC and persistent microchimerism within maternal tissues. Even 4 weeks after delivery, these cells are present in surgical wounds.

摘要

胎儿祖细胞和分化细胞通过胎盘的转移是妊娠过程中的一个已知现象。我们假设,子宫内干细胞移植会导致母体微嵌合体的形成,并且这种现象与胎龄有关。在 E12 或 E13.5 时,将 10(5)个经 EGFP 标记的胎肝来源间充质干细胞(MSC)注射到同基因和同种异体受体胎儿的腹腔内(56 只母体)。在妊娠期间(宫内移植后 1、3 和 7 天)和分娩后(分娩后 1 和 4 周),使用 TaqMan 定量聚合酶链反应(PCR)和荧光显微镜评估母体内移植物的情况。在宫内移植后 1 天,供体细胞主要存在于胎盘(E12:10/10 只母体 vs. E13.5:8/8 只母体)和剖腹术部位(E12:10/10 只母体 vs. E13.5:8/8 只母体)。在宫内移植后 3 天,胎盘内的这种概率明显下降至 3/8 和 1/3,而手术部位增加至 8/8 和 2/4。在宫内移植后 1 周,可在其他单个母体器官(如骨髓或脾脏)中检测到供体细胞。在所有母体中,手术部位均存在嵌合体。在分娩后 1 周,两组的手术部位仍然是主要的植入部位。E12 宫内移植导致母体骨髓(3/4)、肝脏(2/4)、肺(1/4)、脾脏(1/4)和胸腺(1/4)中可检测到供体细胞微嵌合体,而 E13.5 宫内移植后的嵌合概率较低(骨髓:1/4,肝脏:2/4,肺:1/4,脾脏:1/4,胸腺:0/4)。在分娩后 4 周,仅在 E12 宫内移植后,可在各种母体器官(骨髓:1/4,脾脏:1/4,肺:1/4)和新形成的手术部位(3/4)中发现持续的微嵌合体,但在 E13.5 组中完全没有发现。同种异体宫内移植也不会导致任何可检测到的胎儿长期微嵌合体。较早的宫内移植可能导致更多的供体 MSC 通过胎盘转移,并在母体组织中持续存在微嵌合体。即使在分娩后 4 周,这些细胞仍存在于手术部位。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验